NZ512402A - Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale - Google Patents
Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchialeInfo
- Publication number
- NZ512402A NZ512402A NZ51240201A NZ51240201A NZ512402A NZ 512402 A NZ512402 A NZ 512402A NZ 51240201 A NZ51240201 A NZ 51240201A NZ 51240201 A NZ51240201 A NZ 51240201A NZ 512402 A NZ512402 A NZ 512402A
- Authority
- NZ
- New Zealand
- Prior art keywords
- vitamin
- tinnitus
- treatment
- amino acids
- smooth muscle
- Prior art date
Links
- 208000009205 Tinnitus Diseases 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title abstract 2
- 231100000886 tinnitus Toxicity 0.000 title abstract 2
- 239000011573 trace mineral Substances 0.000 title abstract 2
- 235000013619 trace mineral Nutrition 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 2
- 239000004475 Arginine Substances 0.000 title 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title 1
- 229930003268 Vitamin C Natural products 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 238000010276 construction Methods 0.000 title 1
- 229910052749 magnesium Inorganic materials 0.000 title 1
- 239000011777 magnesium Substances 0.000 title 1
- 210000002460 smooth muscle Anatomy 0.000 title 1
- 235000019154 vitamin C Nutrition 0.000 title 1
- 239000011718 vitamin C Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ51240201A NZ512402A (en) | 2001-06-15 | 2001-06-15 | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ51240201A NZ512402A (en) | 2001-06-15 | 2001-06-15 | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ512402A true NZ512402A (en) | 2003-02-28 |
Family
ID=19928516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ51240201A NZ512402A (en) | 2001-06-15 | 2001-06-15 | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ512402A (xx) |
-
2001
- 2001-06-15 NZ NZ51240201A patent/NZ512402A/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2350713A1 (en) | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body | |
| WO2005000161A3 (en) | Methods and devices for occluding body lumens and/or for delivering therapeutic agents | |
| WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| WO2004069146A3 (en) | L-dopa amide derivatives and uses thereof | |
| CA2412789A1 (en) | Compositions for improving mental concentration | |
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| DE60119976D1 (en) | Thixotropes nasenspray | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| UA90893C2 (ru) | Пероральная дозированная форма производных гемцитабина | |
| WO2004058268A3 (de) | Verwendung von tetrahydrobiopterinderivaten zur behandlung und ernährung von patienten mit aminosäurestoffwechselstörungen | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| WO2004056768A3 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| NZ512402A (en) | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale | |
| PT1581239E (pt) | Utilização precoce de um extracto de folhas de videira vermelha | |
| WO2003080568A3 (en) | Probucol derivatives | |
| PT1572686E (pt) | Derivados de amida do ácido antranílico e suas utilizações farmacêuticas | |
| DK1497250T3 (da) | Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse | |
| AU2001262773A1 (en) | Novel oligonucleotide compounds having pyrrolizine derivatives, processes fro preparing them, compositions containing them and uses thereof in treatment, diagnosis and analysis of gene-related diseases | |
| TW200509922A (en) | Methods of therapeutic treatment using amounts of retinoid components | |
| Hu et al. | Cost effectiveness analysis of oseltamivir phosphorus in the treatment of influenza | |
| HUP0402526A3 (en) | Hydroxylamine derivatives useful in the treatment of vascular diseases, pharmaceutical compositions containing them and use thereof | |
| WO2004039978A3 (de) | Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |